Year: 2023

AS Ekspress Grupp to sell the shares of AS Express Post

Written by Customer Service on December 21, 2023. Posted in Public Companies.

AS Õhtuleht Kirjastus, 50% of which owned by AS Ekspress Grupp, entered into a contract to acquire a 100% ownership interest in AS Express Post, which is equally owned by the two largest Estonian media companies, AS Ekspress Grupp and AS Postimees Grupp. The owners of Express Post, which used to operate in the business of home delivery of printed periodicals across Estonia, decided to close the home delivery business at the beginning of this year, and the company has continued to provide call centre and subscriber database management services to periodicals. “The acquisition of Express Post will help strengthen the capability of Õhtuleht Kirjastus in providing the call centre service also to other media companies. The sale of the shares of Express Post is in line with the long-term strategy of Ekspress Grupp, according to which we...

Form 8.3 – GCP Asset Backed Income Fund Limited

Written by Customer Service on December 21, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Foresight Group LLP(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree GCP Asset Backed Income Fund Limited(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

Pilatus Aircraft Ltd To Acquire Pilatus-Focused Aircraft Maintenance Business From Aero Centers

Written by Customer Service on December 21, 2023. Posted in Mergers And Acquisitions.

Aero Centers Will Continue To Operate its FBO and Other Maintenance Activities in Atlanta (PDK) Pilatus To Immediately Assume Pilatus Aircraft Sales Responsibility in Atlanta Area, Pilatus Aircraft Maintenance Responsibilities in 2024 Approximately 40 Aero Centers Employees To Join Pilatus Group ATLANTA and STANS, Switzerland, Dec. 21, 2023 (GLOBE NEWSWIRE) — SAR Trilogy Management, LLC (SAR-T), the holding company of the Aero Centers portfolio of fixed-base operations (FBOs), and Pilatus Aircraft Ltd (Pilatus) today announced that they have entered into a definitive agreement whereby Pilatus will acquire Aero Center’s Pilatus-focused maintenance operations and personnel (MRO) located at the DeKalb-Peachtree Airport in Atlanta, Georgia. The transaction, which is limited to Aero Center’s Pilatus maintenance business and personnel,...

SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools

Written by Customer Service on December 21, 2023. Posted in Mergers And Acquisitions.

Combination Builds Scale and Accelerates Path to Profitability, Unlocking Significant Potential Value for SomaLogic Stockholders Madryn’s Concerns are Not Based on Facts, and Madryn Selectively Ignores Risks in a Standalone Strategy and Potential Benefits of the Merger Urges Stockholders to Vote “FOR” Merger Ahead of Special Meeting of Stockholders on January 4, 2024 BOULDER, Colo., Dec. 21, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc. (Nasdaq: SLGC) today issued an open letter to stockholders highlighting the value maximizing merger entered into with Standard BioTools (Nasdaq: LAB) on October 4, 2023. The Company also filed an investor presentation, which can be found on the investor page of SomaLogic’s website at https://investors.somalogic.com/static-files/daa110f7-0cc3-4eaf-ba78-e0c652b8d7a3. The full text follows: Dear Fellow Stockholders, On...

Wisdomtree Natural Gas 3x Daily Leveraged Securities Proposed Amendment to the Principal Amount of the Affected Securities Adjournment of Meeting of the ETP Securityholders

Written by Customer Service on December 21, 2023. Posted in Public Companies.

21 December 2023 LEI: 2138003QW2ZAYZODBU23 LSE Code: 3NGL WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE NATURAL GAS 3X DAILY LEVERAGED SECURITIESISIN: IE00BLRPRG98 PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt about what action you should take, you are recommended to consult your independent financial adviser. If you have sold or transferred all of your WisdomTree Natural Gas 3x Daily Leveraged Securities (the “Affected Securities”) of WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”), please send this document, together with the accompanying form of proxy, at once to the purchaser...

DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI

Written by Customer Service on December 21, 2023. Posted in Public Companies.

Company seeking commercialization partnerships in the United States, Canada, and Europe to expand revenue generation SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) — DMK Pharmaceuticals Corporation (Nasdaq: DMK) (“DMK”), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders, announces that it has regained the full rights to commercialize ZIMHI® (naloxone) after the termination of an exclusive commercialization and distribution with US WorldMeds, LLC. DMK is now actively seeking commercialization opportunities for ZIMHI, in the United States, Canada, and Europe, focused on new, near-term revenues. In the United States, first responders are the primary target for ZIMHI, where market data demonstrates significant, unmet demand. Eboo...

SELLAS Receives FDA Orphan Drug Designation for SLS009 for Treatment of Peripheral T-cell Lymphomas

Written by Customer Service on December 21, 2023. Posted in Public Companies.

– SLS009 Demonstrated Promising Efficacy in Phase 1 Study with 36.4% Clinical Response (ORR) in r/r Peripheral T-cell Lymphomas (PTCL); ORR in r/r PTCL Patients with Standard of Care is 25.8% – – One Patient with Complete Metabolic Response Continuing Treatment for over 62 weeks and another patient with Complete Response by CT Continuing Treatment for over 24 weeks – – Phase 1b/2 Study in PTCL Ongoing with top line data expected in 1H 2024 – NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD)...

NFT Gaming Company Launches Artificial Intelligence (AI) Game, Jigsaw Puzzle AI, on Apple and Google Play

Written by Customer Service on December 21, 2023. Posted in Public Companies.

The Company’s fourth release for Gaxos, its blockchain gaming platform Roseland, NJ, Dec. 21, 2023 (GLOBE NEWSWIRE) — The NFT Gaming Company, Inc. (“NFTG” or the “Company”), a company developing a digital gaming platform and community that will offer users the ability to create unique avatars playable in all of the games on the platform in the form of non-fungible tokens, or “NFTs,” today announced that the company has launched its fourth game, Jigsaw Puzzle AI for Android and iOS. The game is available to download in the Google Play Store and Apple App Store. To download the game, click here: Jigsaw Puzzle AI “The NFT Gaming Company is extremely pleased to launch our fourth game as we continue to release our suite of games for Gaxos,” said Vadim Mats, CEO of NFT Gaming Company. “Every game is a step toward...

Snail., Inc Unveils Everlasting Winter Wonderland Mod For ARK: Survival Ascended

Written by Customer Service on December 21, 2023. Posted in Public Companies.

Transforming the Land of Dinosaurs into a Winter Wonderland will begin on December 21, 2023, joining the already approved 600+ mods currently available. CULVER CITY, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail” or “the Company”), a leading, global independent developer and publisher of interactive digital entertainment is thrilled to announce a festive transformation in ARK: Survival Ascended as the highly anticipated Winter Wonderland event becomes a permanent fixture as a mod. Beginning today, Survivors across all platforms, including console players, will be able to immerse themselves in the enchanting Winter Wonderland and experience the magic of the season anytime throughout the year. New Winter Wonderland Creatures: Prepare for a host of new creatures to roam the Winter Wonderland landscape,...

Microbix Reports Results for Q4 & Full-Year Fiscal 2023

Written by Customer Service on December 21, 2023. Posted in Earnings Releases And Operating Results.

Full-Year Sales of $16.5 million and Net Loss of $0.04 million MISSISSAUGA, Ontario, Dec. 21, 2023 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its year and fourth quarter ended September 30, 2023 (“2023” & “Q4”), with solid sales and a resumption of profitability in Q4, ongoing progress to increase revenues from its diagnostic-test related ingredients and devices, and recognition of a fully-funded program to revalidate and relaunch its approved drug, Kinlytic® urokinase. Management DiscussionResults for Q4 and 2023 complete a challenging and fulfilling year during which Microbix successfully adapted to post-pandemic conditions – adding important new customers and products, signing a fully-funded redevelopment deal...

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Year: 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals